WESTBOROUGH, MA--(Marketwire - March 04, 2008) - IBC’s Life Sciences is pleased to release new programming for TIDES Oligonucleotide and Peptide® Technology and Product Development Conference which was first released earlier this year. The program now includes the addition of a new course, two new speakers who will present late-breaking data on peptide drugs preclinical and clinical development, and a new panelist in the discussion session on intellectual property.
